Effect of preoperative liraglutide 3.0 mg on incidence of intraoperative adhesions in laparoscopic sleeve gastrectomy
Authors:
Open Access
- 30 September 2024
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 38 (12) , 7152-7157
Abstract
Introduction: Liraglutide has shown promising results in the field of bariatric surgery, preparing patients for surgery. However, chronic therapy is often correlated with gastrointestinal disorders, such as subclinical pancreatitis. The aim of this study was to evaluate the incidence of intraoperative adhesions and post-operative complications in patients undergoing laparoscopic sleeve gastrectomy (LSG) with or without prior therapy with liraglutide. Methods: Clinical records of patients affected by obesity who underwent LSG between March 2017 and October 2022 were retrospectively reviewed using a prospectively maintained database. Patients were separated into two groups: those managed with preoperative liraglutide for 24 weeks prior to LSG, and those without prior medical therapy. Demographic data, operative time, intraoperative adhesions, and postoperative complications were reported and compared between two groups. Results: Ninety-three patients underwent LSG without prior medical therapy, while 87 were treated with liraglutide before surgery. There were no significant differences in terms of gender, age, and comorbidities. After treatment with liraglutide, weight (117 vs 109 kg) and BMI (45 vs 42.2 kg/m2) were statistically lower than the group with no prior treatment to surgery. Thirty-two (37%) patients of the group treated with liraglutide had intraoperative adhesion vs nine (10%) patients of the control group (p < 0.005). There were no differences recorded between the two groups concerning post-operative complications. Conclusion: Liraglutide has introduced a new way to treat obesity, improving weight loss and comorbidities. Gastrointestinal disorders, such as subclinical pancreatitis, associated with GLP-1 analogue could explain the elevated incidence of intraoperative adhesions during bariatric surgery.Keywords
Funding Information
- Universita degli Studi di Bari Aldo Moro
This publication has 19 references indexed in Scilit:
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight ManagementNew England Journal of Medicine, 2015
- Influence of median surgeon operative duration on adverse outcomes in bariatric surgerySurgery for Obesity and Related Diseases, 2015
- A Critical Analysis of the Clinical Use of Incretin-Based TherapiesDiabetes Care, 2013
- Comparative Study for Preventive Effects of Intra-Abdominal Adhesion Using Cyclo-Oxygenase-2 Enzyme (COX-2) Inhibitor, Low Molecular Weight Heparin (LMWH), and Synthetic BarrierYonsei Medical Journal, 2013
- Elevated Amylase and Lipase Levels in Patients Using Glucagonlike Peptide-1 Receptor Agonists or Dipeptidyl-Peptidase-4 Inhibitors In the Outpatient SettingEndocrine Practice, 2012
- Review Article: Adhesion Prevention and Reduction: Current Status and Future Recommendations of a Multinational Interdisciplinary Consensus ConferenceSurgical Innovation, 2010
- Obesity-related non-communicable diseases: South Asians vs White CaucasiansInternational Journal of Obesity, 2010
- The Clavien-Dindo Classification of Surgical ComplicationsAnnals of Surgery, 2009
- Obesity surgery: Evidence-based guidelines of the European Association for Endoscopic Surgery (EAES)Surgical Endoscopy, 2004
- Laparoscopic Roux-en-Y Gastric Bypass: Preoperative Determinants of Prolonged Operative Times, Conversion to Open Gastric Bypasses, and Postoperative ComplicationsObesity Surgery, 2003